MaaT Pharma S.A.
MAAT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €103,994 | €79,328 | €79,134 | €32,394 |
| - Cash | €20,154 | €24,280 | €35,248 | €43,304 |
| + Debt | €15,958 | €14,075 | €11,362 | €5,806 |
| Enterprise Value | €99,798 | €69,123 | €55,248 | -€5,104 |
| Revenue | €3,216 | €2,228 | €1,430 | €972 |
| % Growth | 44.3% | 55.8% | 47.1% | – |
| Gross Profit | €1,966 | €784 | €1,091 | €806 |
| % Margin | 61.1% | 35.2% | 76.3% | 82.9% |
| EBITDA | -€26,344 | -€22,066 | -€13,099 | -€8,570 |
| % Margin | -819.2% | -990.4% | -916% | -881.7% |
| Net Income | -€28,904 | -€19,717 | -€13,713 | -€9,019 |
| % Margin | -898.8% | -885% | -959% | -927.9% |
| EPS Diluted | -2.2 | -1.73 | -1.39 | -3.72 |
| % Growth | -27.2% | -24.5% | 62.6% | – |
| Operating Cash Flow | -€22,041 | -€18,670 | -€12,605 | -€7,929 |
| Capital Expenditures | -€753 | -€1,093 | -€662 | -€238 |
| Free Cash Flow | -€22,794 | -€19,763 | -€13,267 | -€8,167 |